Verana Health Released AI Agents for Research

The new software allows life sciences researchers to query real-world clinical databases using conversational questions.

Updated on Sept. 25, 2026 in Artificial Intelligence

Isometric editorial illustration featuring a clinical glass prism on a laboratory bench, representing complex data research.
San Francisco-based Verana Health has launched AI agents for life sciences researchers to query disease-specific databases using natural language. AI Illustration. Upload story photo >

Live Poll

Do you trust that artificial intelligence tools improve the quality and accuracy of professional research?

San Francisco-based Verana Health has launched AI agents designed to expedite research and development. The tool, known as Agent Claire for Life Sciences, enables users to access disease-specific databases through natural language queries.

Why it matters

By allowing researchers to query complex datasets without requiring programming skills, the product aims to significantly streamline the drug development process. The tool helps ensure efficiency by evaluating execution plans against predefined clinical guardrails.

The software uses specialized clinical training to build execution plans for database navigation. It processes queries by evaluating them against specific clinical guardrails to maintain research integrity.

The players

Verana Health

A San Francisco-based health technology company that focuses on generating real-world evidence for life sciences through clinical data curation.

Agent Claire for Life Sciences

This is the proprietary artificial intelligence software suite designed to assist researchers with database navigation and execution planning.

The details

Agent Claire for Life Sciences bridges the gap between raw medical data and actionable insights by enabling conversational interaction with disease-specific information. The system ensures compliance and accuracy by verifying all user-initiated research plans against established clinical safety protocols.

Timeline

  1. September 24, 2026: Verana Health announced the release of its new AI agents.

The Tech Race

This launch represents a shift toward specialized AI agents that replace traditional manual coding requirements in clinical data analysis. By automating these processes, Verana Health positions itself to compete with other tech firms integrating large language models into highly regulated healthcare environments.

Researchers and data analysts in the life sciences sector can expect improved workflow efficiency by eliminating the need for complex programming when querying large datasets. This technology reduces the technical overhead required to extract insights from real-world clinical evidence.

The takeaway

The move reflects a broader trend of leveraging automated agents to parse complex clinical data for faster pharmaceutical development. Professionals should monitor how these guardrails impact the quality of data outputs compared to human-led queries.

Further reading

Learn more about the latest innovations in Artificial Intelligence impacting the health sector.

Live Poll

Do you trust that artificial intelligence tools improve the quality and accuracy of professional research?